- Home
- MRIN vs QLGN Comparison
MRIN vs QLGN Comparison
Compare MRIN & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRIN
- QLGN
- Stock Information
- Founded
- MRIN 2006
- QLGN 1996
- Country
- MRIN United States
- QLGN United States
- Employees
- MRIN N/A
- QLGN N/A
- Industry
- MRIN EDP Services
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- MRIN Technology
- QLGN Health Care
- Exchange
- MRIN Nasdaq
- QLGN Nasdaq
- Market Cap
- MRIN 1.9M
- QLGN 2.2M
- IPO Year
- MRIN 2013
- QLGN N/A
- Fundamental
- Price
- MRIN $0.97
- QLGN $3.87
- Analyst Decision
- MRIN
- QLGN
- Analyst Count
- MRIN 0
- QLGN 0
- Target Price
- MRIN N/A
- QLGN N/A
- AVG Volume (30 Days)
- MRIN 5.0M
- QLGN 44.7K
- Earning Date
- MRIN 05-23-2025
- QLGN 07-01-2025
- Dividend Yield
- MRIN N/A
- QLGN N/A
- EPS Growth
- MRIN N/A
- QLGN N/A
- EPS
- MRIN N/A
- QLGN N/A
- Revenue
- MRIN $16,707,999.00
- QLGN N/A
- Revenue This Year
- MRIN N/A
- QLGN N/A
- Revenue Next Year
- MRIN N/A
- QLGN N/A
- P/E Ratio
- MRIN N/A
- QLGN N/A
- Revenue Growth
- MRIN N/A
- QLGN N/A
- 52 Week Low
- MRIN $0.41
- QLGN $2.85
- 52 Week High
- MRIN $3.53
- QLGN $29.45
- Technical
- Relative Strength Index (RSI)
- MRIN 49.69
- QLGN 61.76
- Support Level
- MRIN $0.50
- QLGN $3.40
- Resistance Level
- MRIN $1.62
- QLGN $3.95
- Average True Range (ATR)
- MRIN 0.15
- QLGN 0.26
- MACD
- MRIN 0.04
- QLGN 0.03
- Stochastic Oscillator
- MRIN 42.48
- QLGN 69.82
About MRIN Marin Software Incorporated
Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.